FDA NDC Directory · JSON-LD · Markdown

Buprenorphine and Naloxone

NDC 0228-3155 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091422
Dosage form / routeTABLET · SUBLINGUAL
Active ingredientsBUPRENORPHINE HYDROCHLORIDE (8 mg/1)
NALOXONE HYDROCHLORIDE DIHYDRATE (2 mg/1)
Marketing started20130304
Package count1

External sources

Source: openFDA. Public-domain (CC0).